PHARMACOKINETICS OF HALOPERIDOL IN PSYCHOTIC-PATIENTS

被引：44

作者：

CHENG, YF

PAALZOW, LK

BONDESSON, U

EKBLOM, B

ERIKSSON, K

ERIKSSON, SO

LINDBERG, A

LINDSTROM, L

机构：

[1] UNIV UPPSALA,DEPT BIOPHARMACEUT & PHARMACOKINET,BOX 580,S-75123 UPPSALA,SWEDEN

[2] ULLERAKER HOSP,HOSP PHARM,S-75017 UPPSALA,SWEDEN

来源：

PSYCHOPHARMACOLOGY | 1987年 / 91卷 / 04期

关键词：

D O I：

10.1007/BF00216005

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：410 / 414

页数：5

共 15 条

[1]

BENET LZ, 1984, EUR J RESPIR DIS, V65, P45

[2] PLASMA-LEVEL PROFILE OF HALOPERIDOL IN MAN FOLLOWING INTRAMUSCULAR ADMINISTRATION [J].

CRESSMAN, WA ;

BIANCHINE, JR ;

SLOTNICK, VB ;

JOHNSON, PC ;

PLOSTNIEKS, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (02) :99-103

[3] PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY [J].

DAHL, SG .

CLINICAL PHARMACOKINETICS, 1986, 11 (01) :36-61

[4]

FORSMAN A, 1977, CURR THER RES CLIN E, V21, P245

[5]

FORSMAN A, 1978, CURR THER RES CLIN E, V24, P567

[6]

FORSMAN A, 1976, CURR THER RES CLIN E, V20, P319

[7]

FORSMAN A, 1977, CURR THER RES CLIN E, V21, P396

[8] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS [J].

FORSMAN, A ;

MARTENSSON, E ;

NYBERG, G ;

OHMAN, R .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) :113-124

[9] FACTORS AFFECTING DRUG METABOLISM [J].

GILLETTE, JR .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :43-&

[10] HALOPERIDOL KINETICS AFTER ORAL AND INTRAVENOUS DOSES [J].

HOLLEY, FO ;

MAGLIOZZI, JR ;

STANSKI, DR ;

LOMBROZO, L ;

HOLLISTER, LE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (04) :477-484

← 1 2 →